28 Oct Can Mid-Cap Lantheus Continue its 2022 Outperformance?
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test.
Source: Entrepreneur.com Lastest News
Sorry, the comment form is closed at this time.